HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (NASDAQ:OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received FDA 510k clearance for Enhanced Flow Meter (EFM) Visualization which will be utilized on the BleaseSirius Anesthesia System. EFM’s unique visualization feature provides the “touch and feel” to which clinicians are accustomed by displaying an easy to read format using 3-D gas flow tubes and numerical data. With the EFM, the patient data becomes immediately available for export to patient monitoring and hospital information systems.
OSI Systems’ CEO, Deepak Chopra, stated, “We are excited to receive FDA clearance for our Enhanced Flow Meter incorporating cutting edge technology. With several upcoming new product introductions in patient monitoring, anesthesia, cardiology, and data connectivity, we continue to innovate across all of our product platforms and provide hospitals with integrated solutions utilizing the latest technology and help deliver improved patient care.”
About OSI Systems, Inc.
OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. We combine more than 30 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems Inc. or any of its subsidiary companies, visit www.osi-systems.com. News Filter: OSIS-G
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the company's expectations, goals or intentions about the future, including, the Company's contracts to deliver a broad range of solutions to customers in the healthcare industry. The actual results may differ materially from those described in or implied by any forward-looking statement.